- cafead   Apr 25, 2023 at 11:02: AM
via Novartis (NOVN.S) on Tuesday raised its full-year earnings outlook following cost cuts, a breast cancer drug trial success and progress in boosting output of a radiotherapy drug against prostate cancer.
article source
article source